Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

The GPCR OR13A1 is essential for lymphoma cells

Publication ,  Conference
Sartori, G; Cascione, L; Matkovic, M; Matsunami, H; Cavalli, A; Bertoni, F
Published in: CANCER RESEARCH
2022

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2022

Volume

82

Issue

12

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sartori, G., Cascione, L., Matkovic, M., Matsunami, H., Cavalli, A., & Bertoni, F. (2022). The GPCR OR13A1 is essential for lymphoma cells. In CANCER RESEARCH (Vol. 82).
Sartori, Giulio, Luciano Cascione, Milos Matkovic, Hiroaki Matsunami, Andrea Cavalli, and Francesco Bertoni. “The GPCR OR13A1 is essential for lymphoma cells.” In CANCER RESEARCH, Vol. 82, 2022.
Sartori G, Cascione L, Matkovic M, Matsunami H, Cavalli A, Bertoni F. The GPCR OR13A1 is essential for lymphoma cells. In: CANCER RESEARCH. 2022.
Sartori, Giulio, et al. “The GPCR OR13A1 is essential for lymphoma cells.” CANCER RESEARCH, vol. 82, no. 12, 2022.
Sartori G, Cascione L, Matkovic M, Matsunami H, Cavalli A, Bertoni F. The GPCR OR13A1 is essential for lymphoma cells. CANCER RESEARCH. 2022.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2022

Volume

82

Issue

12

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis